Go to the list of all blogs
published in Blogs
Jun 24, 2026
James Hardie Industries (JHX) Delivers +20.6% Gain Over 30 Days on Earnings and Upgrades

James Hardie Industries (JHX) Delivers +20.6% Gain Over 30 Days on Earnings and Upgrades

Key Takeaways

  • JHX shares surged approximately 20.6% over the past 30 days, climbing from $20.01 on May 13, 2026, to $24.13 by June 12, 2026.
  • The rally was fueled by stronger-than-expected Q4 FY26 earnings, upbeat FY27 guidance, and a wave of analyst upgrades from major firms including J.P. Morgan, Citigroup, and Oppenheimer.
  • Over the last quarter, JHX gained roughly 27%, reflecting a broader recovery from deeply oversold levels tied to U.S. housing market concerns and post-acquisition integration uncertainty.
  • Investor sentiment improved markedly as the company demonstrated progress integrating the AZEK acquisition, announced manufacturing cost savings, and expanded strategic distribution partnerships.
  • The stock remains highly sensitive to U.S. housing data, interest rate expectations, and construction activity trends, making macroeconomic developments a critical factor going forward.

James Hardie Industries (JHX) Company Overview and Market Position

James Hardie Industries plc is a global leader in exterior home and outdoor living solutions, headquartered in Dublin, Ireland. The company pioneered fiber cement technology and today manufactures fiber cement siding, trim, backer board, and related building products used extensively in new residential construction and remodeling across North America, Australia, New Zealand, and Europe. Following its transformative acquisition of AZEK in July 2025, James Hardie significantly expanded its portfolio to include composite and PVC decking, railing, and accessories under the TimberTech brand. With approximately $4.84 billion in trailing twelve-month revenue and a market capitalization near $14 billion, JHX is one of the most closely watched building materials stocks, prized by investors as a cyclical play on U.S. housing activity.

James Hardie Industries (JHX) Stock Price Performance: Last 30 Days vs. Quarter

JHX stock delivered a powerful 30-day rally, advancing from an adjusted close of $20.01 on May 13, 2026, to $24.13 on June 12, 2026 — a gain of approximately 20.6%. The move was punctuated by a dramatic two-day swing around the May 19 earnings release, when shares initially dropped 6.05% before roaring back 10.58% the following session as investors digested the full FY27 outlook. Over the broader quarter, JHX climbed roughly 27% from levels near $18.96 in mid-March, marking a sustained recovery from the stock's 52-week low of $16.46 reached in November 2025. The quarterly trend reflects a decisive shift in market sentiment, with JHX breaking above key moving averages and attracting elevated trading volumes that signal renewed institutional interest.

What Drove JHX Stock Price in the Last 30 Days

The primary catalyst behind JHX's 30-day surge was the company's Q4 FY26 earnings release on May 19, 2026, which reported quarterly net sales of $1.4 billion — up 44.5% year-over-year, largely reflecting the contribution from the acquired AZEK business. While net income of $28.5 million came in below some expectations due to integration costs and higher interest expense, management's FY27 outlook struck an optimistic tone, projecting full-year revenue of approximately $5.4 billion and adjusted EBITDA expansion as synergy benefits materialize. The market responded decisively: after an initial post-earnings dip, JHX surged 10.58% on May 20 on massive volume of over 17.6 million shares.

Additional tailwinds included a series of analyst upgrades and bullish initiations. J.P. Morgan upgraded JHX to Overweight in February 2026, and Oppenheimer initiated coverage with an Outperform rating and a $30 price target. Baird and Barclays maintained constructive ratings, while the broader analyst consensus shifted to a Moderate Buy with 76% of covering analysts rating the stock a Buy. The company also announced manufacturing footprint optimization initiatives expected to generate $25 million in annualized cost savings beginning in Q1 FY27, reinforcing the margin expansion narrative. Expanded distribution agreements with Beazer Homes, Green Brick Partners, and CBUSA further underscored commercial momentum.

What Drove JHX Stock Performance Over the Last Quarter

JHX's quarterly advance of approximately 27% represents a meaningful recovery from deeply depressed levels. The stock had been under severe pressure through late 2025 after the company disclosed channel inventory destocking issues that triggered a 34% single-day collapse in August 2025. Lingering concerns about elevated U.S. mortgage rates, affordability headwinds, and integration risks surrounding the AZEK acquisition kept shares pinned near multi-year lows through early 2026. The turnaround gained traction as macroeconomic data began showing tentative stabilization in U.S. housing starts and existing home sales, while the Federal Reserve's rate trajectory became incrementally more favorable for rate-sensitive sectors. Critically, James Hardie's Q3 FY26 results in February 2026 demonstrated organic net sales growth of 1% alongside the AZEK contribution, signaling that the core fiber cement franchise remained resilient. The combination of improving housing data, successful acquisition integration milestones, and a constructive FY27 outlook coalesced to drive the stock's multi-month recovery.

Exploring Data-Driven Trading Approaches

When evaluating stocks like JHX, I sometimes turn to Tickeron's Trending AI Robots page for a curated view of top-performing AI-powered trading bots. Tickeron hosts hundreds of automated trading bots that collectively trade thousands of tickers across diverse strategies, timeframes, and performance metrics. Only the most relevant and consistently high-performing bots appear in this trending section, giving users a streamlined way to explore algorithmic trading tools. Whether favoring short-term momentum strategies or longer-duration swing trading models, the page provides a practical starting point for evaluating AI-driven trading approaches alongside traditional research.

JHX Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, several factors will shape JHX's trajectory. The next earnings report, estimated for August 17, 2026, will be pivotal — analysts are forecasting Q1 FY27 EPS of approximately $0.31 on revenue of $1.31 billion, and any deviation from these expectations could trigger significant price movement. U.S. housing market data, including building permits, housing starts, and mortgage rate trends, will remain the dominant macro driver given JHX's deep cyclical exposure. The pace of AZEK integration and realization of projected cost synergies will be closely scrutinized, as will the company's ability to manage its elevated debt load of approximately $4.79 billion following the acquisition. Competitive dynamics with peers such as Eagle Materials and Masco also warrant attention. Finally, any shifts in Federal Reserve policy or changes in U.S. trade and tariff frameworks affecting building materials could materially impact the investment case for JHX.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: JHX

JHX in -5.64% downward trend, declining for three consecutive days on August 18, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where JHX declined for three days, in of 328 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for JHX moved out of overbought territory on August 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where JHX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for JHX turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

JHX broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on JHX as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JHX advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 228 cases where JHX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.701) is normal, around the industry mean (2.522). JHX's P/E Ratio (138.318) is considerably higher than the industry average of (30.746). Projected Growth (PEG Ratio) (1.240) is also within normal values, averaging (1.698). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (3.283) is also within normal values, averaging (2.431).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JHX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JHX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.

Notable companies

The most notable companies in this group are Cemex SAB de CV (NYSE:CX).

Industry description

Many naturally occurring substances, such as clay, rocks, sand, and wood, even twigs and leaves have been used in construction material. Many man-made products are also in use. Vulcan Materials Co., Martin Marietta Materials, Inc. and Owens Corning Inc. are examples of construction material companies in the U.S. Performance of companies that extract or produce construction materials could at times depend on demand for residential and commercial buildings/real estate, and therefore in some cases could feel impacted by economic cycles.

Market Cap

The average market capitalization across the Construction Materials Industry is 12.44B. The market cap for tickers in the group ranges from 323.7K to 63.25B. CRH holds the highest valuation in this group at 63.25B. The lowest valued company is CAPT at 323.7K.

High and low price notable news

The average weekly price growth across all stocks in the Construction Materials Industry was -2%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -13%. RETO experienced the highest price growth at 23%, while CAPS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Construction Materials Industry was 41%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 42
Price Growth Rating: 64
SMR Rating: 61
Profit Risk Rating: 71
Seasonality Score: -52 (-100 ... +100)
View a ticker or compare two or three
JHX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of cement products

Industry ConstructionMaterials

Profile
Details
Industry
Construction Materials
Address
Harcourt Street
Phone
+353 14116924
Employees
5473
Web
https://ir.jameshardie.com.au
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.